Comiskey, Michael C.
Dallos, Matthew C.
Drake, Charles G.
Article History
First Online: 18 August 2018
Compliance with Ethics Guidelines
:
: Michael C. Comiskey declares that he has no conflict of interest.Matthew C. Dallos declares that he has no conflict of interest.Charles G. Drake has received research support through grants from Janssen, Bristol-Myers Squibb, and Aduro Biotech; has compensation from Agenus, Dendreon, ImmunExcite, Janssen, Lilly, Merck, Pierre Fabre, and Roche/Genentech for service as a consultant; is a stockholder of Compugen, Potenza, Tizona, and Kleo; and has patents licensed to Janssen, AZ Immune, and Bristol-Myers Squibb.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
Free to read: This content has been made available to all.